Abstract submission is now open for the 2026 NYC Neuromodulation Conference. July 30 - August 3, 2026 | New York City. Learn more

Neuromodec Journal

Publishing original research and analysis in the fields of neuromodulation devices, brain interface technology, and digital brain therapeutics.
Neuromodec Journal’s publishing model integrates scientific journal rigor with dynamic (web) content, at no cost to authors or readers, with rapid turn-around.

Featured Articles

arom Bikson interviews: Harold Sackeim on “Wired for Depression”
Article | Open Access
Marom Bikson interviews: Harold Sackeim on “Wired for Depression”

Neuromodec
Published online: September 2025

NYC Neuromodulation 2024 Abstract in Brain Stimulation Journal
News | Open Access
2024 NYC Neuromodulation Conference Abstracts published in Brain Stimulation Journal

Neuromodec
Published online: August 2025

Article Image 1
Article | Open Access
Perspective by Dr. Kip Ludwig: What does the recent Neuralink FDA IDE really mean?

Kip Ludwig
Published online: June 2023

Article Image 1
Article | Open Access
What Silicon Valley needs to know about the brain, and what it doesn't. Part 2: Definitions

Marom Bikson
Published online: January 2023

Top Picks

Article | Open Access
Employee Vulnerabilities Affected by the Use of Neurowearable Technology in the Workplace

James Giordano
Published online: October 2024

Article Image 4
Article | Open Access
Neuromodulation Design and Biomarkers

Marom Bikson
Published online: September 2023

Article Image 4
Article | Open Access
Neuromodulatory Technology: Through the Lens and In the Mirror

James Giordano
Published online: December 2023

Article Image 4
Article | Open Access
What Silicon Valley needs to know about the brain, and what it doesn't. Part I

Marom Bikson
Published online: November 2021

Article Image 3
Article | Open Access
Bridging the gap between scientific research and clinical practice in TMS and TES

Alexander Sack
Published online: March 2023

Article Image 4
Article | Open Access
EU regulators grossly misrepresent non-invasive brain stimulation

Balder Onarheim
Published online: January 2023

Article Image 4
Article | Open Access
Is Neuralink the First Hook in a Neurobioeconomic – and Ethico-legal and Social - Chain Reaction?

James Giordano
Published online: February 2024

Proceedings

Proceeding | Open Access
State dependent modulation of cognitive control by prefrontal transcranial magnetic stimulation

Aaron N McInnes et al.
Published online: October 2024

Proceeding | Open Access
White Matter Network Differentially Mediates Language Cognition in response to cTBS Transcranial Magnetic Stimulation

Shreya Parchure et al.
Published online: October 2024

Proceeding | Open Access
Synaptic depotentiation with early low-frequency TMS reduces hyperactivity after neonatal hypoxia in mice

Ivan Goussakov et al.
Published online: October 2024

Proceeding | Open Access
Towards Efficient Search For Personalized TMS Therapy

Jacob Tajchman et al.
Published online: October 2024

Proceeding | Open Access
Optimized interferential stimulation of human brains is sensitive to head anatomies and target locations

Tapasi Brahma et Al.
Published online: October 2024

Read more articles

Neuromodulation for COVID-19 Updates

Neuromodulation for COVID-19 update 10: Major Steps forward
Read More
Neuromodulation for COVID-19 update 9: More encouraging studies
Read More
Neuromodulation for COVID-19, Neuromodec update 8: Encouraging news
Read More
Neuromodulation for COVID-19, Neuromodec update 7: Electronic noses, NIH “RECOVER” recruits’ patients, New prospects.
Read More
Neuromodulation for COVID-19, Neuromodec update 6: Breakthrough studies show efficacy pathways
Read More
Neuromodulation for COVID-19 update 5: Increased urgency to developed neuromodulation treatments, ongoing taVNS results
Read More
Neuromodec update 4: More evidence for Long-Covid and taVNS for Depressive Symptoms
Read More

News & Updates

Important updates on targeted neuromodulation for depression, Abbott DBS and SAINT TMS
Read More
2021 Neuromodec Highlights in Neuromodulation
Read More
NeuroPace received FDA nod for IDE trial on closed-loop neuromodulation therapy for idiopathic generalized epilepsy (IGE)
Read More
National Institutes of Health (NIH) award team of medical centers $10m to test Synchron brain interface technology
Read More
Neuromodulation plus Digital Therapeutics
Read More
Tivic Health Accelerates Wearable Neuromodulation with Consumers in Mind
Read More
Neurolief announces FDA clearance and Japan partnership
Read More
Safety and Efficacy of Adaptive Deep Brain Stimulation
Read More